PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology
Clinical trial NCT05592665 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05592665
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-18
- Primary completion
- 2027-01-16
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.